These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8724673)

  • 1. Pupil dilatation assay by tropicamide is modulated by apolipoprotein E epsilon 4 allele dosage in Alzheimer's disease.
    Arai H; Terajima M; Nakagawa T; Higuchi S; Mochizuki H; Sasaki H
    Neuroreport; 1996 Mar; 7(4):918-20. PubMed ID: 8724673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E epsilon 4 allele and pupillary response to tropicamide.
    Higuchi S; Matsushita S; Hasegawa Y; Muramatsu T; Arai H; Hayashida M
    Am J Psychiatry; 1997 May; 154(5):694-6. PubMed ID: 9137131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pupil response to tropicamide in Alzheimer's disease and other neurodegenerative disorders.
    Gómez-Tortosa E; del Barrio A; Jiménez-Alfaro I
    Acta Neurol Scand; 1996 Aug; 94(2):104-9. PubMed ID: 8891054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pupillary response to tropicamide in Japanese patients with alcoholic dementia, Alzheimer's disease, and vascular dementia.
    Higuchi S; Matsushita S; Hasegawa Y; Muramatsu T; Arai H
    Exp Neurol; 1997 Mar; 144(1):199-201. PubMed ID: 9126171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experience with pupil tropicamide test in Alzheimer's disease].
    Robles A; Touriño R; Sesar A; Suárez P; Noya M
    Rev Neurol; 1996 Jan; 24(125):65-8. PubMed ID: 8852002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ApoE allelic variability influences pupil response to cholinergic challenge and cognitive impairment.
    Scinto LF
    Genes Brain Behav; 2007 Apr; 6(3):209-15. PubMed ID: 16764677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-evaluation of tropicamide in the pupillary response test for Alzheimer's disease.
    Iijima A; Haida M; Ishikawa N; Ueno A; Minamitani H; Shinohara Y
    Neurobiol Aging; 2003 Oct; 24(6):789-96. PubMed ID: 12927761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pupil assay and Alzheimer's disease: a critical analysis.
    Scinto LF; Rentz DM; Potter H; Daffner KR
    Neurology; 1999 Feb; 52(3):673-4. PubMed ID: 10025819
    [No Abstract]   [Full Text] [Related]  

  • 9. Why patients with Alzheimer's disease may show increased sensitivity to tropicamide eye drops: role of locus coeruleus.
    Hou RH; Samuels ER; Raisi M; Langley RW; Szabadi E; Bradshaw CM
    Psychopharmacology (Berl); 2006 Jan; 184(1):95-106. PubMed ID: 16308726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pupil dilation response to tropicamide: a biological test for Alzheimer's disease?
    Kurz A; Marquard R; Fremke S; Leipert KP
    Pharmacopsychiatry; 1997 Jan; 30(1):12-5. PubMed ID: 9065964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological markers for the clinical diagnosis of Alzheimer's disease.
    Arai H
    Tohoku J Exp Med; 1996 Jun; 179(2):65-79. PubMed ID: 8875763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tropicamide effects on pupil size and pupillary light reflexes in Alzheimer's and Parkinson's disease.
    Granholm E; Morris S; Galasko D; Shults C; Rogers E; Vukov B
    Int J Psychophysiol; 2003 Feb; 47(2):95-115. PubMed ID: 12568941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mydriatic effect of tropicamide and its diagnostic use in Alzheimer's disease.
    Reitner A; Baumgartner I; Thuile C; Baradaran Dilmaghani R; Ergun E; Kaminski S; Lukas J; Dal Bianco P
    Vision Res; 1997 Jan; 37(1):165-8. PubMed ID: 9068838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor test (pupillary dilatation after application of 0.01% tropicamide solution) and determination of central nervous activation (Fourier analysis of pupillary oscillations) in patients with Alzheimer's disease.
    Grünberger J; Linzmayer L; Walter H; Rainer M; Masching A; Pezawas L; Saletu-Zyhlarz G; Stöhr H; Grünberger M
    Neuropsychobiology; 1999; 40(1):40-6. PubMed ID: 10420100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased mydriatic response to tropicamide is a sign of cholinergic hypersensitivity but not specific to late-onset sporadic type of Alzheimer's dementia.
    Kálmán J; Kanka A; Maglóczky E; Szóke A; Járdánházy T; Janka Z
    Biol Psychiatry; 1997 Apr; 41(8):909-11. PubMed ID: 9099419
    [No Abstract]   [Full Text] [Related]  

  • 16. Tropicamide eyedrops cannot be used for reliable diagnosis of Alzheimer's disease.
    Graff-Radford NR; Lin SC; Brazis PW; Bolling JP; Liesegang TJ; Lucas JA; Uitti RJ; O'Brien PC
    Mayo Clin Proc; 1997 Jun; 72(6):495-504. PubMed ID: 9179132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pupil dilation to tropicamide is not specific for Alzheimer disease.
    Growdon JH; Graefe K; Tennis M; Hayden D; Schoenfeld D; Wray SH
    Arch Neurol; 1997 Jul; 54(7):841-4. PubMed ID: 9236572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of the effects of 2% ibopamine, 10% phenylephrine, and 1% tropicamide on the anterior segment.
    Marchini G; Babighian S; Tosi R; Perfetti S; Bonomi L
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):281-9. PubMed ID: 12506086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of the pupil to tropicamide is not a reliable test for Alzheimer disease.
    FitzSimon JS; Waring SC; Kokmen E; McLaren JW; Brubaker RF
    Arch Neurol; 1997 Feb; 54(2):155-9. PubMed ID: 9041856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the mydriatic effects of mydrin-P and compound tropicamide in the screening of retinopathy of prematurity.
    Luo S; Wan Z; Yin X; Ye Z; Lu Y
    Eye Sci; 2014 Dec; 29(4):219-22. PubMed ID: 26016074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.